Searched for
MANKIND PHARMA IPO
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...
Rupee at 95, crude at $120+: Why India's markets are flying blind into a stormMarket expert Sudip Bandyopadhyay warns Indian markets face significant risks. High oil prices and a potential monsoon deficit are major co...
Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
Mankind Pharma's success boosts hopes of more consumer IPOs in IndiaThe strong performance of Mankind Pharma Ltd. in the stock market is expected to lead to more consumer-related initial public offerings (IP...
Mankind Pharma shares list at 20% premium over IPO priceThe IPO, valued at Rs 4,326 crore, received an overwhelming response, being subscribed for 15.32 times due to interest from qualified insti...
Mankind Pharma IPO: What GMP signals ahead of listing on TuesdayMankind Pharma is set to list on May 9 with a premium of Rs 120 apiece according to grey market trends. The company is valued at a price-to...
Mankind Pharma set for stellar debut on Tuesday, Street sees 8-10% listing premiumMankind Pharma's shares are commanding a premium of Rs 100-113 to its issue price of Rs 1,080 in the grey market. Research analysts predict...
Mankind Pharma IPO: GMP rises ahead of likely share allotment tomorrow. Here's how to check statusMankind Pharma's Rs 4,326 crore initial public offering (IPO), the largest by a domestic drug maker so far in 2021 and with a 15.32 times s...
Mankind Pharma IPO subscribed 15.32 timesThis will be one of the largest public issues by a domestic drug manufacturer after the ₹6,480-crore IPO of Gland Pharma in 2020. The quali...
Mankind Pharma IPO sails through on Day 3Around nine brokerages have given "subscribe" recommendations on the issue, with some of them seeing the potential in the long term. Analys...
Mankind Pharma IPO subscribed 32% so far on Day 2. Check GMP and other details.Mankind Pharma's initial public offering (IPO), which will close on January 19, has been subscribed by 32% on Day 2 with non-institutional ...
Mankind Pharma IPO opens for subscription today: Should you bid?Indian pharma giant Mankind Pharma has launched its initial public offering (IPO), with around 40 million equity shares available for sale....
Mankind Pharma IPO subscribed 14% on Day 1; GMP inches up at Rs 90-95The Rs 4,300-crore IPO, solely an offer for sale (OFS), will be available for public to bid till April 27. Investors can bid for 13 shares ...
Mankind Pharma IPO now open: Here's how it stacks up against its peersThe Issue comprises an offer for sale (OFS) of about 40 million equity shares and will be open for subscription till April 27.
Mankind Pharma IPO opens on Tuesday. What GMP suggests for potential investors?The company has fixed a price band of Rs 1,026-1,080 for its IPO, which is completely an offer for sale (OFS) of 40 million equity shares b...
Mankind Pharma IPO: 10 things to know about the biggest issue so far this yearIndian pharma company Mankind Pharma is set to open its IPO next week. The offer for sale of 40 million equity shares by promoters and othe...
Mankind Pharma announces IPO price band at Rs 1,026-1,080At the upper end of the price band, the fourth largest pharmaceutical company in terms of domestic sales will be valued at ₹43,264 crore. T...
Mankind Pharma sets IPO price band at Rs 1,026-1,080The IPO is entirely an offer for sale (OFS) by promoters and existing investors who are looking to divest their stakes in the Delhi-based p...
Mankind Pharma IPO to open for subscription on April 25The company has hired Kotak Investment Banking, Axis Capital, IIFL Securities, Jefferies and JP Morgan as book-running lead managers while ...
Mankind Pharma files DRHP for Rs 5,500 crore IPOThe company’s initial public offering comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.The ...